Screener
King Pharmaceuticals KG Deferred Tax Assets
Deferred Tax Assets at other companies
Other financials
Where this comes from
Reported directly by King Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:DeferredTaxAssetsDeferredIncome.
The source filing: King Pharmaceuticals’s 10-Q, filed August 7, 2026. Open the filing →
- Filed
- Aug 7, 2026, 8:49 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054606
FAQ
- What is King Pharmaceuticals's deferred tax assets?
- King Pharmaceuticals (KG) reported deferred tax assets of $0 in Q2 2026.
- What does deferred tax assets mean?
- Future tax benefits from temporary differences, net operating loss carryforwards, and tax credit carryforwards that will reduce future tax payments.
Ask your AI about King Pharmaceuticals's deferred tax assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude